Press release
Global Dermatomyositis - Pipeline Insight and Therapeutic Assessment Reviewed in 2017
market Research hub
Click here for Free Sample Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1381804
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Pipeline Review, H2 2017, provides an overview of the Dermatomyositis (Musculoskeletal Disorders) pipeline landscape.
Dermatomyositis is a rare inflammatory disease which is characterized by chronic muscle inflammation accompanied by muscle weakness. Symptoms of dermatomyositis include a distinctive skin rash, muscle weakness, and inflammatory myopathy, or inflamed muscles. Risk factors include age and gender. Treatment includes corticosteroids.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Dermatomyositis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Dermatomyositis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Dermatomyositis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dermatomyositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 6, 4 and 1 respectively.
Dermatomyositis (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Dermatomyositis (Musculoskeletal Disorders).
- The pipeline guide reviews pipeline therapeutics for Dermatomyositis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Dermatomyositis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Dermatomyositis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Dermatomyositis (Musculoskeletal Disorders)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Dermatomyositis (Musculoskeletal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Dermatomyositis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Browse Full Report with TOC@ https://www.marketresearchhub.com/report/dermatomyositis-pipeline-review-h2-2017-report.html
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Dermatomyositis - Overview 7
Dermatomyositis - Therapeutics Development 8
Pipeline Overview 8
Pipeline by Companies 9
Products under Development by Companies 10
Dermatomyositis - Therapeutics Assessment 11
Assessment by Target 11
Assessment by Mechanism of Action 13
Assessment by Route of Administration 15
Assessment by Molecule Type 17
Dermatomyositis - Companies Involved in Therapeutics Development 19
Bristol-Myers Squibb Co 19
Chugai Pharmaceutical Co Ltd 19
Eli Lilly and Co 20
Hope Pharmaceuticals Inc 20
Idera Pharmaceuticals Inc 21
KPI Therapeutics Inc 21
MedImmune LLC 21
Neovacs SA 22
Novartis AG 22
Octapharma AG 23
Pfizer Inc 23
Dermatomyositis - Drug Profiles 25
abatacept - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
baricitinib - Drug Profile 35
Product Description 35
Mechanism Of Action 35
R&D Progress 35
dalazatide - Drug Profile 47
Product Description 47
Mechanism Of Action 47
R&D Progress 47
immune globulin (human) - Drug Profile 52
Product Description 52
Mechanism Of Action 52
R&D Progress 52
IMO-8400 - Drug Profile 55
Product Description 55
Mechanism Of Action 55
R&D Progress 55
lenabasum - Drug Profile 61
Product Description 61
Mechanism Of Action 61
R&D Progress 61
MEDI-7734 - Drug Profile 70
Product Description 70
Mechanism Of Action 70
R&D Progress 70
PF-06823859 - Drug Profile 71
Product Description 71
Mechanism Of Action 71
R&D Progress 71
siponimod - Drug Profile 72
Product Description 72
Mechanism Of Action 72
R&D Progress 72
sodium thiosulfate - Drug Profile 75
Product Description 75
Mechanism Of Action 75
R&D Progress 75
tocilizumab - Drug Profile 76
Product Description 76
Continued….
Enquire about this Report@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1381804
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceutical industry reports and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Dermatomyositis - Pipeline Insight and Therapeutic Assessment Reviewed in 2017 here
News-ID: 832993 • Views: …
More Releases from Market Research Hub
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the…
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the…
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section…
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the…
More Releases for Dermatomyositis
Dermatomyositis Treatment Market – segmentation up to the second or third leve …
Dermatomyositis is a form of inflammatory myopathy in which degenerative and inflammatory changes occur in the skin and the muscles. It is a rare form of acquired muscle disease that is accompanied by skin rashes. Symptoms of dermatomyositis may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs (proximal muscles), the hips, the upper arms, and the…
Dermatomyositis Treatment Market– Current Trends, Opportunities & Challenges b …
The report analyzes and presents an overview of "Dermatomyositis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025" worldwide.
The objectives of this study are as follows:
To define, describe, and forecast the "Dermatomyositis Treatment" market by type, application, component, delivery model, end user, and region
To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To analyze micromarkets with respect to…
Dermatomyositis Treatment Market Size, Share & Trend | Industry Report, 2017-202 …
Dermatomyositis is a form of inflammatory myopathy in which degenerative and inflammatory changes occur in the skin and the muscles. It is a rare form of acquired muscle disease that is accompanied by skin rashes. Symptoms of dermatomyositis may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs (proximal muscles), the hips, the upper arms, and the…
Dermatomyositis Treatment Market - New Products Features & Forecast 2017 - 2025
Dermatomyositis is a form of inflammatory myopathy in which degenerative and inflammatory changes occur in the skin and the muscles. It is a rare form of acquired muscle disease that is accompanied by skin rashes. Symptoms of dermatomyositis may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs (proximal muscles), the hips, the upper arms, and the…
Dermatomyositis Drug Sales Market 2022 - Opportunities, Challenges, Strategies, …
Report Bazzar has released its latest research-based report entitled ‘Dermatomyositis Drug Sales market.' This comprehensive report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Dermatomyositis Drug Sales Market worldwide along with the key trends and latest technologies, playing a prominent role in the Dermatomyositis Drug Sales market growth over the predicted period. It also takes into account…
Global Dermatomyositis Drug Market Size, Share, Outlook and Forecast Report 2017
The research report on the Global dermatomyositis drug market research report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of “Global dermatomyositis drug market research report 2017” and provides deep insights into…
